Key Financial Data Of Group

SANTEN PHARMACEUTICAL CO.,LTD. - Filing #7254751

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
188,101,000,000 JPY
195,238,000,000 JPY
196,589,000,000 JPY
190,828,000,000 JPY
186,112,000,000 JPY
Ordinary profit (loss)
26,232,000,000 JPY
31,272,000,000 JPY
27,068,000,000 JPY
22,525,000,000 JPY
25,324,000,000 JPY
Net assets
153,446,000,000 JPY
187,505,000,000 JPY
199,261,000,000 JPY
297,507,000,000 JPY
294,231,000,000 JPY
Total assets
237,652,000,000 JPY
271,848,000,000 JPY
282,904,000,000 JPY
363,763,000,000 JPY
353,603,000,000 JPY
Net assets per share
449.15
515.75
529.72
742.30
734.61
Basic earnings (loss) per share
51.03
50.88
-153.18
43.59
54.44
Diluted earnings per share
50.89
50.74
43.53
54.33
Equity-to-asset ratio
0.645 xbrli:pure
0.689 xbrli:pure
0.703 xbrli:pure
0.817 xbrli:pure
0.831 xbrli:pure
Rate of return on equity
0.105 xbrli:pure
0.097 xbrli:pure
-0.239 xbrli:pure
0.059 xbrli:pure
0.075 xbrli:pure
Price-earnings ratio
27.8 xbrli:pure
30.2 xbrli:pure
xbrli:pure
28.1 xbrli:pure
28.0 xbrli:pure
Number of employees
3,849 xbrli:pure
1,756 xbrli:pure
3,744 xbrli:pure
1,676 xbrli:pure
1,807 xbrli:pure
4,144 xbrli:pure
4,318 xbrli:pure
1,842 xbrli:pure
4,232 xbrli:pure
1,875 xbrli:pure
Revenue
300,004,000,000 JPY
301,965,000,000 JPY
279,037,000,000 JPY
266,257,000,000 JPY
249,605,000,000 JPY
Profit (loss) before tax
47,481,000,000 JPY
29,874,000,000 JPY
-5,799,000,000 JPY
35,616,000,000 JPY
11,688,000,000 JPY
Profit (loss), attributable to owners of parent
36,256,000,000 JPY
26,642,000,000 JPY
-14,948,000,000 JPY
27,218,000,000 JPY
9,311,000,000 JPY
Comprehensive income, attributable to owners of parent
29,340,000,000 JPY
39,991,000,000 JPY
-5,658,000,000 JPY
38,660,000,000 JPY
18,204,000,000 JPY
Equity attributable to owners of parent
286,242,000,000 JPY
306,055,000,000 JPY
293,979,000,000 JPY
337,488,000,000 JPY
310,181,000,000 JPY
Total assets
409,277,000,000 JPY
435,699,000,000 JPY
421,179,000,000 JPY
459,976,000,000 JPY
405,285,000,000 JPY
Owners' equity per share
839.20
843.24
783.30
843.60
776.16
Basic earnings (loss) per share
103.98
72.59
-38.60
68.07
23.30
Diluted earnings (loss) per share
103.68
72.37
-38.60
67.97
23.26
Ratio of owners' equity to gross assets
0.699 xbrli:pure
0.702 xbrli:pure
0.698 xbrli:pure
0.734 xbrli:pure
0.765 xbrli:pure
Rate of return on equity
0.122 xbrli:pure
0.089 xbrli:pure
-0.047 xbrli:pure
0.084 xbrli:pure
0.030 xbrli:pure
Price-earnings ratio
13.6 xbrli:pure
21.2 xbrli:pure
xbrli:pure
18.0 xbrli:pure
65.4 xbrli:pure
Cash flows from (used in) operating activities
60,928,000,000 JPY
72,649,000,000 JPY
37,147,000,000 JPY
46,043,000,000 JPY
38,808,000,000 JPY
Cash flows from (used in) investing activities
-8,223,000,000 JPY
-6,145,000,000 JPY
-26,777,000,000 JPY
-35,169,000,000 JPY
-53,355,000,000 JPY
Cash flows from (used in) financing activities
-53,307,000,000 JPY
-34,031,000,000 JPY
-37,220,000,000 JPY
5,557,000,000 JPY
-16,685,000,000 JPY
Cash and cash equivalents
92,997,000,000 JPY
94,582,000,000 JPY
57,903,000,000 JPY
83,014,000,000 JPY
62,888,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.